Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer

Fig. 1

Differential expression analyses and gene expression signature for each group. The differentially expressed mRNAs (A), miRNAs (B) and lncRNAs (C) of plasma-derived exosomes enriched fraction between responders and non-responders to NACT. (D) The identified panel of exosomal RNAs including 9 miRNAs, 5mRNAs and 4 lncRNAs, to discriminate potential responders to NACT in AGC patients. (E) The PCA method was used to describe gene expression signatures of candidate exosomal RNAs in responders and non-responders. (G) The expression levels of 8 verified exosomal RNAs with differential expression and consistent expression trend. (H) The ROC analyses of verified 8 exosomal RNAs

Back to article page

Molecular Cancer

ISSN: 1476-4598